Both a Danish and an English version of the Investor Portal is available. 

To log-on to the Investor Portal use your VP-reference or MitID:

Access Novo Nordisk Investor Portal (UK)

Log på Novo Nordisk Investor Portal (DK)

The Investor Portal is administered by Computershare A/S. Learn how Computershare A/S process personal data.

This also applies to notices to convene general meetings which are no longer sent to shareholders as hardcopy by regular mail.

Shareholders are encouraged to sign up and register their email address via Novo Nordisk A/S’ InvestorPortal

Shareholders who wish to receive company information are responsible for ensuring that Novo Nordisk A/S is in possession of the correct email address and should sign up via the InvestorPortal. Learn more about how to sign-up your email.

Receipt of electronic communication from Novo Nordisk requires access to an email and a pdf-viewer.

Announcements of a general nature will be made available at

Holders of such certificates were thus encouraged to contact Danske Bank, Corporate Actions, via contact details below no later than 4 November 2018 in order to have their shareholdings registered and the physical certificates converted into registered shares in Novo Nordisk A/S and Novozymes A/S.

If the conversion was not completed by 4 November 2018, the corresponding shares have been sold pursuant to the Danish Companies Act. Holders of physical share certificates and interim certificates will be entitled to collect the net proceeds of the share sale within a period of three years following the sale.

See the announcement as published on for further information (in Danish).

The above applies to holders of physical share certificates and interim certificates in former Nordisk Gentofte A/S and Novo Industri A/S only and does not affect shareholders of registered shares in Novo Nordisk A/S.

Danske Bank, 3886 Corporate Actions,
Holmens Kanal 2-12, 1092 København K,
Telephone: (+45) 45 14 36 94

To change your email address, please log on to the investor portal. 

In our InvestorPortal guideline (pdf) you can learn how to add or update your email address.


Stock information

{{}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Download Annual Report